Arcutis Biotherapeutics, Inc. is rolling out its Free to Be Me awareness campaign featuring actress Tori Spelling and her daughter, Stella (17). Through Free to Be Me, Spelling shares her story of working with her healthcare provider to manage her and her daughter’s skin conditions with the help of roflumilast (Zoryve, Arcutis).
Her journey, like so many others, included trying countless prescription and over-the-counter products to help calm her and her daughter’s skin before finally finding a long-term treatment option with the help of her clinician.
“Managing a chronic skin condition like eczema isn’t just about appearance—It’s about how you feel, how you show up for yourself and family, and how confidently you live your life,” says Spelling in a news release. “Both my daughter and I have struggled with eczema, and she has also lived with seborrheic dermatitis, so we know how frustrating and persistent these skin conditions can be. Finding ZORYVE, a once-daily, steroid-free topical that works to clear the redness and itching, while being gentle on our skin, has truly changed the way we manage our skin diseases. And having clearer skin has helped us feel more confident in our own skin every day.”
“Throughout my career, I have seen firsthand how chronic skin conditions like eczema and seborrheic dermatitis can take their toll, affecting not only the skin, but one’s overall quality of life from work to play,” adds Adam Friedman, MD, FAAD, Professor and Chair of Dermatology at the George Washington University School of Medicine and Health Sciences in Washington, D.C., in a news release. “Because these are lifelong conditions, patients need treatment options that are both safe and effective for the long haul. These include nonsteroidal topicals like ZORYVE, which in turn gives patients and healthcare practitioners confidence that we can manage these diseases continuously without compromise.”
